Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Butyrophilins in Colon Cancers Aggressiveness Evaluation
NCT04185272Recruiting
- Sponsor
- Institut Paoli-Calmettes
- Start
- Jun 2020
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Institut Paoli-Calmettes. Primary endpoint: Evaluation of BTNL3, BTNL8 and BTNL9 expression at 8 years. Started Jun 2020; status: recruiting.
Beyond the preview
Go deeper on NCT04185272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04185272.